Literature DB >> 1465050

The vitamin D/parathyroid hormone axis in the pathogenesis of hypertension and insulin resistance in uremia.

R H Mak1, J H Wong.   

Abstract

Recent evidence suggests a pathogenetic link between hypertension and insulin resistance. In addition, disturbances of vitamin D/parathyroid hormone axis have been reported in various hypertensive and insulin-resistant states. Chronic renal failure is characterized by high incidence of hypertension, insulin resistance and disturbances in the vitamin D/parathyroid hormone axis. Preliminary studies in both patients and rats with end-stage renal disease who were hypertensive, insulin resistant and 1,25-dihydroxycholecalciferol deficient with hyperparathyroidism; parenteral administration of pharmacological doses of 1,25-dihydroxycholecalciferol led to reversal of hypertension and insulin resistance without significant changes in serum calcium or parathyroid hormone concentrations. Thus, vitamin D deficiency may be an important factor in the pathogenesis of hypertension and insulin resistance in end-stage renal disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1465050

Source DB:  PubMed          Journal:  Miner Electrolyte Metab        ISSN: 0378-0392


  4 in total

1.  Impact of activated vitamin D on insulin resistance in nondiabetic chronic kidney disease patients.

Authors:  David J Friedman; Nisha Bhatt; Najwah S Hayman; Brendan J Nichols; Mark Herman; Nikolay Nikolaev; John Danziger
Journal:  Clin Endocrinol (Oxf)       Date:  2012-07       Impact factor: 3.478

Review 2.  Vitamin D deficiency and toxicity in chronic kidney disease: in search of the therapeutic window.

Authors:  Uwe Querfeld; Robert H Mak
Journal:  Pediatr Nephrol       Date:  2010-06-22       Impact factor: 3.714

Review 3.  Vitamin D deficiency in chronic liver disease.

Authors:  Paula Iruzubieta; Álvaro Terán; Javier Crespo; Emilio Fábrega
Journal:  World J Hepatol       Date:  2014-12-27

4.  Improvement in glucose tolerance and beta-cell function in a patient with vitamin D deficiency during treatment with vitamin D.

Authors:  S Kumar; M Davies; Y Zakaria; E B Mawer; C Gordon; A O Olukoga; A J Boulton
Journal:  Postgrad Med J       Date:  1994-06       Impact factor: 2.401

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.